Oncostatin M induces the differentiation of breast cancer cells

International Journal of Cancer

Volumn 75, Issue 1, 1998, Pages 64-73

  Douglas, Andrea M ^a   Grani, Susan L ^a   Goss, Geraldine A ^a   Clousion, David R ^a   Sulhirland, Robert L ^a   Beflly, C Glenn ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOSTATIN M;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL JUNCTION; CYTOARCHITECTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE C FOS; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DENSITY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL COUNT; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CYCLINS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENES, FOS; GENES, MYC; GROWTH INHIBITORS; GROWTH SUBSTANCES; HUMANS; ONCOSTATIN M; PEPTIDES; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0032484511     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980105)75:1<64::AID-IJC11>3.0.CO;2-D     Document Type: Article

References (39)

1. ALEXANDER, I.E., SHINE, J. and SUTHERLAND, R.L., Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells. Mol. Endocrinol., 4, 821-828 (1987).
2. BATES, S.F., DAVIDSON, N.B., VALNERIUS, E.M., DICKSON, R.B., FRETER, C.E., TAM, J.P., KUDLOW, J.E., LIPPMAN, M.E. and SOLOMON, D.S., Expression of transforming growth factor alpha and its mRNA in human breast cancer: its regulation by estrogen and its possible functional signilicance. Mol. Endocrinol., 2, 543-555 (1988).
3. BROWS, T.J., ROWE, J.M., LIU, J.W. and SHOVAB, M., Regulation of IL-6 expression by oncostatin M. J. Immunol., 147, 2175-2180 (1991).
4. BROWN, T.J. and SHOYAB, M., Differential effects of leukemia inhibitory factor (LIF) and oncostatin M (Onco M) on endothelial cell (EC) physiology. J. Cell Physiol. (Suppl.). 15F, 247 (1991).
5. BRUCE, A.G., HOGGATT, I.H. and ROSE, T.M., Oncostatin M is a differentition factor for myeloid leukemia cell. J. Immunol., 149, 1271-1275 (1992).
6. BUTIA, A., MACLENNAN, K., FLANDERS, K.C., SACKS, N.P.M., SMITH, I., MCKINNA, A., DOWSETT, M., WAKEFIELD, L.M., SPORN, M.B., BAUM, M. and COLLETTA, A.A., Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res., 52, 4261-4264 (1992).
7. DAVIDSON, N.E., GELMANN, E.P., LIPPMAN, M.E. and DICKSON, R.B., Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol. Endocrinol., 1, 216-223 (1987).
8. DICKSON, R.B. and LIPMANN, M.E., Breast cancer: cellular and molecular biology, pp. 119-165. Kluwer, Boston (1988).
9. DICKSON, R.B. and LIPMANN, M.E., Molecular determinants of growth, angiogenesis, and metastases in breast cancer. Semin. Oncol., 19, 286-298 (1992).
10. DOUGLAS, A.M., GOSS, G.A., SUTHERLAND, R.L., HILTON, D.J., BERNDT, M.C., NICOLA, N.A. and BEGLEY, C.G., Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene. 14, 661-669 (1997).
11. GEARING, D.P., COMEAU, M.R., FRIEND, D.J., GIMPEI, S.D., THUT, C.J., MCGOURTY, J., BRASHEK, K.K., KING, J.A., GILLIS, S., MOSLEY, B., ZIEGER, S.F., and COSMAN, D., The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity convertor for the LIF receptor. Science, 255, 1434-1437 (1992).
12. GROVE, R.I., EBERHARDT, C., ABID, S., MAZZUCCO, C., LIU, J., KIENER, P., TODARO, G. and SHOYAB, M., Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc. nat. Acad. Sci. (Wash.), 90, 823-827 (1993).
13. GUILBAUD, N.F., GAS, N., DUPONT, M.A. and VALETTE, A., Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells. J. cell. Physiol. 145, 162-172 (1990).
14. HARRIS, A.L., What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer? Breast Cancer Res. Treat., 29, 1-2 (1994).
15. HENDERSON, B.E., ROSS, R. and BERNSTEIN, L., Estrogens as a cause of human cancer. Cancer Res., 48, 246-253 (1988).
16. HILTON, D.J., MILTON, A.A., RAICEVIC, A., RAKAR, S., HARRISON-SMITH, M., GOUGH, N.M., BEGLEY, C.G., MEICALE., D., NICOLA, N.A. and WILLSON, T.A., Cloning of a murine IL-11 receptor α-chain: requirement for gp130 for high affinity binding and signal transduction. EMRO J., 13, 4765-4775 (1994).
17. HORN, D., FITZPATRICK, W.C., GOMPPER, P.T., OCHS, V., BOLTON-HANSEN, M., ZARIJNG, J., MALIK, N., TODARO, G.J. and LINSLEY, P.S., Regulation of cell growth by recombinant oncostatin M. Growth Factors. 2, 157-165 (1990).
18. KNABBE, C., WAKEFIELD, L., FLANDERS, K., KASID, A., DERYNCK, R., LIPPMAN, M.E. and DICKSON, R.B., Lvidence that TGF beta is a hormonally regulated negative growth factor in human breast cancer. Cell, 48, 417-428 (1987).
19. LEE, C.S.L., HALL, R.E., ALEXANDER, LE., KOGA, M., SHINE, J. and SUIHERLAND, R.L., Inverse relationship between estrogen receptor and epidermal growth factor receptor mRNA levels in human breast cancer cell lines. Growth Factors. 3, 97-103 (1990).
20. MILLS, S.A., MARTINEZ-MAZA, O., REZAI, A., MAGPANTAY, L., KISHIMOTO, T., NAKAMURA, S., RADKA, S.F. and LINSLEY, P.S., Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science, 255, 1432-1434 (1992).
21. MIYAJIMA, A., HARA, T. and KITAMURA, T., Common subunits of cytokine receptors and the functional redundancy of cytokines. Trends biochem. Sci., 17, 378-382 (1992).
22. MURPHY, L.J., SUTHERLAND, R.L., STEED, B., MURPHY, L.C., and LAZARUS, L., Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Mol. Endrocrinol. 46, 728-734 (1986).
23. MUSGROVE, H.A., HAMILTON, J.A., LEE, C.S.L., SWEENEY, K.J.E., WATTS, C.K.W. and SUTHERLAND, R.L., Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T47D human breast cancer cell cycle progression. Mol. cell. Biol., 13, 3577-3587 (1993).
24. MUSGROVE, E.A., LEE, C.S.L. and SUTHERLAND, R.L., Progestins both stimulate and inhibit cancer cell cycle progression while increasing expression of transforming growth factor α. epidermal growth factor receptor. c-fos and c-myc genes. Mol.cell. Biol., 11, 5032-5043 (1991).
25. OFT, M., PELI, J., RUDAZ, C., SCMWARZ, H., BEUG, H. and REICHMANN, E., TGF-beta-1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Develop., 10, 2462-2477 (1996).
26. PENNICA, D., KING, K.I., SHAW, K.J., LUIS, E., RULLAMAS, J., LUOH, S., DARBONNE, W.C., KUNTZON, D.S., YEN, R., CHIEN, K.R., BAKER, J.B. and WOOD, W.I., Expression cloning of cardiotrophin L, a cytokine that induces cardiac myocyte hypertrophy. Proc. nat. Acad. Sci. (Wash.), 92, 1142-1146 (1995).
27. ROSE, T.M. and BRUCE, A.G., Oncostalin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin-6. Proc. nat. Acad. Sci. (Wash.), 88, 8641-8645 (1991).
28. SANTEN, R.J., MANNI, A., HARVEY, H. and REDMOND, C., Endocrine treatment of breast cancer in women. Endocrine Rev., 11, 221-265 (1990).
29. SHEIKH, M.S., SHAO, Z., CHEN, J., LI, X., HUSSAIN, A. and FONTANA, J.A., Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGFR) and transforming growth factor α (TGFα) gene expression. J. Cell Biochem., 54, 289-298 (1994).
30. SHERR, C. J., MATSUSHIME, H. and ROUSSEL., M.F.. Regulation of CYL/cyclin D genes by colony-stimulating factor. Ciba Foundation Symposium, 170, 209 (1992).
31. STEWART, A.J., JOHNSON, M.D., MAY, F.E.B. and WESTLEY, B.R., Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. biol. Chem., 265, 21172-21178 (1990).
32. TAMM, I., CARDINALE, I., KIKUCHI, T. and KRUEGER, J.G., E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells. Proc. nat. Acad. Sci. (Wash.), 91, 4338-4342 (1994).
33. TANIGAWA, T., NICOLA, N., MCARTHUR, G.A., STRASSER, A. and BEGLEY, C.G., Differential regulation of macrophage differentiation in response to LIF/OSM/IL-6: the effect of enforced expression of the SCL. transcription factor. Blood, 85, 379-390 (1995).
34. VANDERBIUI, J.N., MIESEFLD, R., MALER, B.A. and YAMAMOTO, K.R., Intercellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol. Endocrinol., 1, 68-74 (1987).
35. WARING, P.M., WARING, L.J., BILLINGTON, T. and METCALF, D., Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc. nat. Acad. Sci. (Wash.), 92, 1337-1341 (1995).
36. WELSCH, C.W., Host factors affecting the growth of carcinogen-induced rat mamman carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res., 45, 3415-3443 (1985).
37. WESTENDORE, J.J. and JELINEK, D.F., Growth regulatory pathways in myeloma: esidence for autocrine oncostatin M expression. J. Immunol., 157, 3081-3088 (1996).
38. YOSHIMURA, A., ICHIHARA, M., KlNJYO, I., MORIYAMA, M., CoPELAND, N.G., GILBERT, D.J., JENKINS, N.A., HARN, T. and MIYAJIMA, A., Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J., 15, 1055-1063 (1996).
39. ZARUING, J.M., SHOYAB, M., MAROUARDI, M., HANSON, M.B., LIOUBIN, M.N. and TODNRO, G.J., Oncostatin M: a growth regulator produced by differentiated histrocytic lymphoma cells. Proc. nat. Acad. Sci. (Wash.), 83, 9739-9743 (1986).